Operating Lease, Right-of-Use Asset of Design Therapeutics, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Design Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • Design Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,637,000, a 32% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Design Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,637,000 -$764,000 -32% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $1,834,000 -$749,000 -29% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $2,027,000 -$735,000 -27% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $2,216,000 -$722,000 -25% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $2,401,000 -$710,000 -23% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $2,583,000 -$697,000 -21% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 $2,762,000 -$685,000 -20% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $2,938,000 -$674,000 -19% 31 Dec 2023 10-K 10 Mar 2025 2024 FY
Q3 2023 $3,111,000 -$662,000 -18% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $3,280,000 -$652,000 -17% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $3,447,000 -$35,000 -1% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $3,612,000 -$2,000 -0.06% 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q3 2022 $3,773,000 +$30,000 +0.8% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $3,932,000 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $3,482,000 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $3,614,000 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q3 2021 $3,743,000 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.